List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 26 studies with search of:   "Eosinophilia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
Conditions: Asthma;   Eosinophilia;   Helminthiasis;   Hypersensitivity;   Parasitic Disease
Intervention:
2 Completed L-5-HTP-Related EMS
Condition: Eosinophilia-Myalgia Syndrome
Intervention:
3 Active, not recruiting Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
Conditions: Eosinophilia;   Hypereosinophilic Syndrome
Intervention: Drug: Gleevec
4 Recruiting A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
Condition: Eosinophilia
Intervention:
5 Recruiting Montelukast in the Treatment of Duodenal Eosinophilia
Conditions: Eosinophilic Gastroenteritis;   Dyspepsia
Intervention: Drug: montelukast
6 Recruiting Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
Conditions: Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease;   Food Allergy
Intervention:
7 Recruiting Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: Imatinib Mesylate
8 Completed Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
Condition: Hypereosinophilic Syndrome
Intervention: Drug: SCH55700
9 Recruiting The Efficacy of Three Months-Prednisolone Therapy for Chronic Eosinophilic Pneumonia
Conditions: Eosinophilic Pneumonia;   Chronic Disease
Interventions: Drug: prednisolone 0.5mg/kg/day for three months;   Drug: prednisolone 0.5mg/kg/day for six months
10 Recruiting Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
Conditions: Hypereosinophilic Syndrome;   Chronic Eosinophilic Leukemia (CEL);   Myeloproliferative Disorders
Intervention: Drug: STI571
11 Recruiting Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)
Condition: Drug Hypersensitivity
Intervention: Drug: Tegeline®
12 Completed Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Conditions: Hypereosinophilic Syndrome;   Hypereosinophilia
Intervention: Drug: mepolizumab
13 Active, not recruiting Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Conditions: Hypereosinophilic Syndrome;   Hypereosinophilia
Intervention: Drug: mepolizumab
14 Completed Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
Conditions: Hypereosinophilic Syndrome;   Chronic Eosinophilic Leukemia;   Chronic Idiopathic Hypereosinophilia
Intervention: Drug: Imatinib
15 Active, not recruiting The Prednisone-Sparing Effect of Anti-IL-5 Antibody (SB-240563)
Condition: Asthma
Intervention: Drug: SB-240563 (Mepolizumab)
16 Recruiting Data Bank for Eosinophilic Disorders
Conditions: Eosinophilic Esophagitis;   Gastritis;   Enteritis;   Eosinophilic Colitis;   Eosinophilic Gastroenteritis
Intervention:
17 Active, not recruiting A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
Condition: Eosinophilic Esophagitis
Intervention: Drug: Fluticasone Propionate
18 Active, not recruiting A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
Conditions: Chronic Myelogenous Leukemia;   Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive);   Hypereosinophilic Syndrome;   Systemic Mastocytosis
Intervention: Drug: AMN107
19 Recruiting Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Conditions: Hypereosinophilic Syndrome;   Systemic Mastocytosis;   Chronic Myelomonocytic Leukemia;   Dermatofibrosarcoma
Intervention: Drug: imatinib mesylate
20 Active, not recruiting Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Agnogenic Myeloid Metaplasia;   Myelofibrosis;   Hypereosinophilic Syndrome;   Polycythemia Vera;   Mastocytosis;   Leukemia, Myelomonocytic, Chronic
Intervention: Drug: Dasatinib (BMS-354825)

Previous Page Studies Shown (1-20) Next (21-26)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services